{"nct_id":"NCT03345082","title":"A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD","status":"COMPLETED","status_verified_date":"2020-01","start_date":"2017-11-06","start_date_type":"ACTUAL","primary_completion_date":"2019-05-14","primary_completion_date_type":"ACTUAL","completion_date":"2019-05-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["OPT"]}